114 related articles for article (PubMed ID: 11312617)
1. Isolation and characterization of bacteriophage-resistant mutants of Vibrio cholerae O139.
Attridge SR; Fazeli A; Manning PA; Stroeher UH
Microb Pathog; 2001 Apr; 30(4):237-46. PubMed ID: 11312617
[TBL] [Abstract][Full Text] [Related]
2. Vibrio cholerae O139 capsular polysaccharide confers complement resistance in the absence or presence of antibody yet presents a productive target for cell lysis: implications for detection of bactericidal antibodies.
Attridge SR; Holmgren J
Microb Pathog; 2009 Dec; 47(6):314-20. PubMed ID: 19818394
[TBL] [Abstract][Full Text] [Related]
3. The Vibrio cholerae O139 serogroup antigen includes an O-antigen capsule and lipopolysaccharide virulence determinants.
Waldor MK; Colwell R; Mekalanos JJ
Proc Natl Acad Sci U S A; 1994 Nov; 91(24):11388-92. PubMed ID: 7972070
[TBL] [Abstract][Full Text] [Related]
4. [Noncapsular mutants of Vibrio cholerae serogroup O139: their isolation, identification and use for the preparation of an O139 diagnostic antiserum].
Chekhovskaia GV; Shchelkanova EIu; Smirnova NI
Zh Mikrobiol Epidemiol Immunobiol; 2000; (1):34-7. PubMed ID: 10876889
[TBL] [Abstract][Full Text] [Related]
5. Molecular mechanisms of virstatin resistance by non-O1/non-O139 strains of Vibrio cholerae.
Shakhnovich EA; Sturtevant D; Mekalanos JJ
Mol Microbiol; 2007 Dec; 66(6):1331-41. PubMed ID: 17986190
[TBL] [Abstract][Full Text] [Related]
6. The capsule and O antigen in Vibrio cholerae O139 Bengal are associated with a genetic region not present in Vibrio cholerae O1.
Comstock LE; Maneval D; Panigrahi P; Joseph A; Levine MM; Kaper JB; Morris JG; Johnson JA
Infect Immun; 1995 Jan; 63(1):317-23. PubMed ID: 7528734
[TBL] [Abstract][Full Text] [Related]
7. Characterizing lipopolysaccharide and core lipid A mutant O1 and O139 Vibrio cholerae strains for adherence properties on mucus-producing cell line HT29-Rev MTX and virulence in mice.
Schild S; Lamprecht AK; Fourestier C; Lauriano CM; Klose KE; Reidl J
Int J Med Microbiol; 2005 Aug; 295(4):243-51. PubMed ID: 16128399
[TBL] [Abstract][Full Text] [Related]
8. Novel Vibrio cholerae O139 genes involved in lipopolysaccharide biosynthesis.
Stroeher UH; Parasivam G; Dredge BK; Manning PA
J Bacteriol; 1997 Apr; 179(8):2740-7. PubMed ID: 9098074
[TBL] [Abstract][Full Text] [Related]
9. Identification of genes involved in biosynthesis of Actinobacillus pleuropneumoniae serotype 1 O-antigen and biological properties of rough mutants.
Labrie J; Rioux S; Wade MM; Champlin FR; Holman SC; Wilson WW; Savoye C; Kobisch M; Sirois M; Galarneau C; Jacques M
J Endotoxin Res; 2002; 8(1):27-38. PubMed ID: 11981443
[TBL] [Abstract][Full Text] [Related]
10. Construction and characterization of a potential live oral carrier-based vaccine against Vibrio cholerae O139.
Favre D; Cryz SJ; Viret JF
Infect Immun; 1996 Sep; 64(9):3565-70. PubMed ID: 8751900
[TBL] [Abstract][Full Text] [Related]
11. [Phenotypic analysis of two morphologically different types of Vibrio cholerae 0139 colonies].
Smirnova NI; Chekhovskaia GV; Davydova NI; Livanova LF; Eroshenko GA; Ostroumova NM
Mol Gen Mikrobiol Virusol; 1995; (3):30-4. PubMed ID: 7477037
[TBL] [Abstract][Full Text] [Related]
12. [Role of moderate bacteriophage 139 in change in production of cholera toxin in a classic strain of Vibrio cholerae].
Eroshenko GA; Smirnova NI
Genetika; 2004 Apr; 40(4):445-53. PubMed ID: 15174276
[TBL] [Abstract][Full Text] [Related]
13. The ability of two different Vibrio spp. bacteriophages to infect Vibrio harveyi, Vibrio cholerae and Vibrio mimicus.
Payne M; Oakey J; Owens L
J Appl Microbiol; 2004; 97(4):663-72. PubMed ID: 15357715
[TBL] [Abstract][Full Text] [Related]
14. [Genetic analysis of mutations affecting the synthesis of somatic O-antigen of Vibrio cholerae].
Smirnova NI; Il'ina TS; Livanova LF; Smirnov GB
Mol Gen Mikrobiol Virusol; 1985 Oct; (10):3-8. PubMed ID: 2432416
[TBL] [Abstract][Full Text] [Related]
15. The evolution of epidemic Vibrio cholerae strains.
Mooi FR; Bik EM
Trends Microbiol; 1997 Apr; 5(4):161-5. PubMed ID: 9141191
[TBL] [Abstract][Full Text] [Related]
16. [Construction of plasmid gene bank of V. cholerae O139 and detection of O-antigen genes].
Qu D; Liu C; Zhang Y; Ma Q
Wei Sheng Wu Xue Bao; 2001 Feb; 41(1):65-9. PubMed ID: 12549191
[TBL] [Abstract][Full Text] [Related]
17. Diversity of Vibrio cholerae strains isolated in Delhi, India, during 1992-2000.
Das S; Gupta S
J Health Popul Nutr; 2005 Mar; 23(1):44-51. PubMed ID: 15884751
[TBL] [Abstract][Full Text] [Related]
18. Isolation and characterization of unserotypable lysogens of Vibrio cholerae phage PS166.
Basu S; Ghosh RK
Med Sci Monit; 2005 Sep; 11(9):BR335-42. PubMed ID: 16127356
[TBL] [Abstract][Full Text] [Related]
19. Phagocytosis of Vibrio cholerae O139 Bengal by human polymorphonuclear leukocytes.
Albert MJ; Qadri F; Bhuiyan NA; Ahmad SM; Ansaruzzaman M; Weintraub A
Clin Diagn Lab Immunol; 1999 Mar; 6(2):276-8. PubMed ID: 10066668
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the Vibrio cholerae vexAB and vexCD efflux systems.
Bina JE; Provenzano D; Wang C; Bina XR; Mekalanos JJ
Arch Microbiol; 2006 Sep; 186(3):171-81. PubMed ID: 16804679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
